Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong
· Delayed Price · Currency is HKD 1.220
-0.010 (-0.81%)
Mar 18, 2025, 2:27 PM HKT
HKG:2348 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 17, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 1,832 | 1,575 | 1,993 | 2,502 | 2,107 | 2,221 | Upgrade
|
| Market Cap Growth | 0.88% | -20.98% | -20.34% | 18.77% | -5.13% | -4.77% | Upgrade
|
| Enterprise Value | 221 | 503 | 1,004 | 1,638 | 1,060 | 1,199 | Upgrade
|
| Last Close Price | 1.22 | 0.98 | 1.16 | 1.35 | 1.06 | 1.02 | Upgrade
|
| PE Ratio | 3.03 | 4.39 | 4.92 | 5.69 | 6.62 | 7.77 | Upgrade
|
| Forward PE | - | 8.59 | 8.59 | 8.59 | 8.59 | 8.59 | Upgrade
|
| PS Ratio | 1.58 | 1.24 | 1.38 | 1.75 | 1.73 | 2.09 | Upgrade
|
| PB Ratio | 0.52 | 0.50 | 0.67 | 0.85 | 0.81 | 0.98 | Upgrade
|
| P/TBV Ratio | 0.62 | 0.58 | 0.77 | 1.00 | 0.94 | 1.13 | Upgrade
|
| P/FCF Ratio | 10.90 | 10.30 | 7.67 | 25.46 | 10.83 | 8.20 | Upgrade
|
| P/OCF Ratio | 5.32 | 4.23 | 4.06 | 5.19 | 5.86 | 7.20 | Upgrade
|
| EV/Sales Ratio | 0.19 | 0.40 | 0.70 | 1.15 | 0.87 | 1.13 | Upgrade
|
| EV/EBITDA Ratio | 0.70 | 1.29 | 1.85 | 3.08 | 2.39 | 3.14 | Upgrade
|
| EV/EBIT Ratio | 1.01 | 1.65 | 2.12 | 3.50 | 2.78 | 3.69 | Upgrade
|
| EV/FCF Ratio | 1.32 | 3.29 | 3.86 | 16.67 | 5.45 | 4.43 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.04 | 0.00 | 0.01 | 0.00 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 0.59 | 0.34 | 0.02 | 0.05 | 0.01 | 0.64 | Upgrade
|
| Debt / FCF Ratio | 1.20 | 0.87 | 0.04 | 0.29 | 0.02 | 0.91 | Upgrade
|
| Asset Turnover | 0.28 | 0.32 | 0.36 | 0.37 | 0.36 | 0.37 | Upgrade
|
| Inventory Turnover | 2.16 | 2.31 | 2.30 | 2.18 | 2.24 | 2.60 | Upgrade
|
| Quick Ratio | 3.03 | 2.24 | 1.59 | 1.72 | 2.69 | 2.45 | Upgrade
|
| Current Ratio | 3.40 | 2.57 | 1.87 | 2.17 | 3.23 | 2.77 | Upgrade
|
| Return on Equity (ROE) | 18.41% | 11.71% | 14.10% | 15.46% | 12.58% | 12.94% | Upgrade
|
| Return on Assets (ROA) | 3.77% | 4.73% | 7.47% | 7.62% | 7.04% | 7.04% | Upgrade
|
| Return on Capital (ROIC) | 4.54% | 6.12% | 10.31% | 10.33% | 9.04% | 8.71% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.76% | 9.34% | 15.29% | 14.41% | 13.22% | 13.40% | Upgrade
|
| Earnings Yield | 33.02% | 22.80% | 20.31% | 17.57% | 15.11% | 12.87% | Upgrade
|
| FCF Yield | 9.18% | 9.71% | 13.04% | 3.93% | 9.23% | 12.19% | Upgrade
|
| Dividend Yield | 6.50% | 8.16% | 7.60% | 5.91% | 6.11% | 5.66% | Upgrade
|
| Payout Ratio | 19.86% | 35.91% | 27.80% | 40.18% | 30.44% | 40.28% | Upgrade
|
| Buyback Yield / Dilution | 0.07% | -0.02% | 0.37% | 2.44% | 1.89% | 0.69% | Upgrade
|
| Total Shareholder Return | 6.57% | 8.14% | 7.97% | 8.35% | 8.00% | 6.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.